A Randomized Controlled Clinical Trial on the Antipyretic Efficacy of Oral Paracetamol, Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever to Emergency Department
Sponsor study identifier
interventional
434
1 country
1
Study Start
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2011
Actual (reported)Study Completion
April 2013
Actual (reported)A randomized clinical trial to check the antipyretic efficacy of oral and intravenous paracetamol and intramuscular diclofenac sodium in patients presenting with fever to emergency department.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2013
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
December 2011
Actual (reported)April 2013
Actual (reported)June 21, 2013
Actual (reported)July 3, 2013
Actual (reported)Reduction in temperature in every thirty minutes till 120 minutes after receiving antipyretics
Once the patients fulfill the inclusion criteria, they are randomly assigned to receive one of the three medications in the study ( oral paracetamol, intravenous paracetamol or intramuscular diclofenac). Baseline temperature is recorded using a standard thermometer. Then reduction in temperature is recorded every 30 minutes for 2 hours.
Reduction in temperature is checked every 30 minutes for a maximum of 120 minutes
patients in this arm will receive 1000mg of oral paracetamol
patients in this arm will receive 1000 mg of intravenous paracetamol
patients in this arm will receive 75 mg of intramuscular diclofenac sodium
after giving medicine temperature is checked every 30 minutes for 2 hours
after giving medicine temperature is checked every 30 minutes for 2 hours
Hamad medical corporation
Doha, 3050, Qatar
osama H Mohammed
Hamad Medical Corporation
434 participants (actual enrollment reported by the registry).
First Submitted
June 21, 2013
First Posted
July 3, 2013
Study Start
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
Procalcitonin in Fever of Unknown Etiology
after giving medicine temperature is checked every 30 minutes for 2 hours
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
December 2011
Actual (reported)Study Completion
April 2013
Actual (reported)Last Updated
July 3, 2013
Record last verified: 2013-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: